Regeneron (REGN) FDA Committee Votes Against ARCALYST Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. SPY
3. AAPL
4. XPEV
5. DKS
6. USO
7. VEEV
8. GRML
9. BMO
10. HEEVF

Go back to Regeneron (REGN) FDA Committee Votes Against ARCALYST Approval
Regeneron (NASDAQ: REGN) Delayed: 833.56 +5.06 (0.61%)
Previous Close $828.50    52 Week High $592.36 
Open $829.22    52 Week Low $325.35 
Day High $839.94    P/E 218.78 
Day Low $823.44    EPS $3.81 
Volume 505,419